PatternsRadar
Sign in

SURAKSHASuraksha Diagnostic Limited

NSE
Full chart
332.00INR+0.15 (+0.05%)Close · 6 Oct 2026
13 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹1,729 CrMarket cap
48.1P/E (TTM)
42.6%Delivery

Filings & corporate actions

9 results filed
CSV
Next results · Q2 FY27
Expected 5 Nov 2026 – 21 Dec 2026
Estimate: filed 36–82 days after quarter end, last 8 times
Dividend
₹0.50 per share · last 15 Sept 2026
2026
  • 15 SeptdividendDividend · ₹0.50 per share-0.2%
  • 13 AugresultsResults · Q1 FY27 · consolidated+12.6%NSE
  • 12 AugresultsResults · Q1 FY27 · standalone+12.6%NSE
  • 22 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone-2.2%NSE
  • 4 AprshareholdingShareholding · 31 Mar 2026+2.2%NSE
  • 13 FebresultsResults · Q3 FY26 · standalone0.0%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated+0.8%NSE
  • 17 JanshareholdingShareholding · 31 Dec 2025-2.1%NSE

Reaction to results · all yearsrose on day 0 in 2 of 8 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2712 Aug 2026+12.6%+12.9%+21.3%32.9×
Q4 FY2621 May 2026-2.2%-12.0%-12.9%3.3×
Q3 FY265 Feb 2026+0.8%-0.3%-8.9%1.0×
Q2 FY2610 Nov 2025-2.8%-6.4%-13.8%1.5×
Q1 FY268 Aug 2025-0.5%+6.9%+2.9%2.7×
Q4 FY2528 May 2025-2.9%-1.3%-0.8%1.1×
Q3 FY258 Feb 2025-4.6%-17.3%-24.4%1.0×
Q2 FY2521 Dec 2024-1.9%-8.9%-18.4%—
Average-0.2%-3.3%-6.9%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+20.7%
Profit YoY+40.0%
Interest cost YoY+52.3%
Revenue QoQ+7.7%
Profit QoQ+108.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open330.20
Day range325.15 – 334.70
52-week range224.10 – 360.00
From 52w high-7.8%
RSI (14)48.1
ATR (14)14.74
Volume57.5K
Avg volume (20D)95.4K
Rel volume0.60×
Volatility (1Y)34.1%
Turnover₹1.9Cr
SMA 50 / 200312.56 / 283.19

Delivery percentage

Latest · 6 Oct 202642.6%
20-day avg53.7%
1-year avg59.2%
Percentile (own history)14th
Range13.9–92.6%
Sessions454

Over the last 20 sessions SURAKSHA settled 53.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 59.2%, so recent sessions are running 5.5 points lower than usual. The latest session ranks higher than 14% of the 454 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHealthcare Service Provider

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.05%-4.34%-2.24%+23.26%+35.52%+11.41%

Valuation

CSV
Market cap₹1,729 Cr
P/E (TTM)48.1
EPS (TTM)6.91
Shares outstanding5.21Cr
Listed6 Dec 2024

Ownership

CSV
Promoter49.10%
Promoter Δ QoQ0.00 pp
Public50.90%
FII13.47%
DII23.23%
Pledged0.10%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)78.777.781.487.6
YoY chg+17.9%+30.5%+25.1%+20.7%
Net profit (₹ Cr)8.87.26.212.8
YoY chg-13.1%+21.0%-14.1%+40.0%
Net margin11.2%9.3%7.6%14.7%
EPS1.731.441.212.50

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 49.10% · public 50.90%
5 Dec 2024: promoter 48.78%31 Dec 2024: promoter 48.78%31 Mar 2025: promoter 48.78%30 Jun 2025: promoter 48.88%30 Sept 2025: promoter 48.98%31 Dec 2025: promoter 49.00%31 Mar 2026: promoter 49.10%30 Jun 2026: promoter 49.10%
2024-122026-06
  • Promoter
  • Public and others
Promoter
49.10%
Public
50.90%
Promoter change
0.00 pp
Filed
22 Jul 2026
FII
13.47%
DII
23.23%
Promoter pledged
0.10%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26RQ4 FY26AQ1 FY27
Revenue from operations66.859.565.172.678.777.781.487.6
Other income1.30.60.80.90.90.60.81.1
Total income68.160.165.973.579.678.382.288.7
Total expenses54.452.156.761.067.568.272.272.2
└ Finance costs2.12.02.12.72.83.23.93.7
└ Depreciation8.78.88.79.510.110.611.311.3
Profit before tax13.68.09.212.512.010.110.016.5
Tax expense3.52.12.03.33.22.83.83.7
Net profit10.26.07.29.28.87.26.212.8
EPS1.941.181.421.801.731.441.212.50
Net margin15.21%10.06%11.02%12.64%11.21%9.32%7.57%14.66%
PBT margin20.42%13.52%14.15%17.18%15.30%12.95%12.26%18.86%
Tax rate25.51%25.63%22.16%26.41%26.72%28.03%38.29%22.27%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 13 Aug 2026.

SURAKSHA at a glance

  • SURAKSHA closed at ₹332 on 6 Oct 2026, +0.05% on the day, +11.4% over one year, 7.8% below its 52-week high of ₹360.
  • Delivery was 42.6% of traded quantity on 6 Oct 2026, the 14th percentile of its own 454 sessions with a reading (20-session average 53.7%, 1-year average 59.2%).
  • Market capitalisation is ₹1,729 crore at a trailing P/E of 48.1 (trailing EPS ₹6.91).
  • Q1 FY27 results (consolidated, filed 12 Aug 2026): revenue ₹88 crore (+20.7% year on year), net profit ₹13 crore (+40.0%); the price moved +12.6% on the first session after.
  • Promoters held 49.10% at 30 Jun 2026, unchanged on the previous filing, with 0.10% of promoter shares pledged.
  • Q2 FY27 results are expected between 5 Nov 2026 and 21 Dec 2026, going by past filing dates — an estimate, not an announcement.